المؤلفون: Perez-de-Llano L, Scelo G, Canonica G.W, Chen W, Henley W, Larenas-Linnemann D, Peters M.J, Pfeffer P.E, Tran T.N, Ulrik C.S

المصدر: Universidad de La Sabana ; Intellectum Repositorio Universidad de La Sabana

مصطلحات موضوعية: Biological product, Corticosteroid, Immunoglobulin E Antibody, Interleukin 5 antibody, Antiasthmatic agent, Adolescent, Adult

وصف الملف: application/pdf

Relation: Annals of Allergy, Asthma and Immunology Vol. 132 N° 5; http://hdl.handle.net/10818/62184

الاتاحة: http://hdl.handle.net/10818/62184
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85183534197&doi=10.1016%2fj.anai.2023.12.023&partnerID=40&md5=1c875704f8e22b80a67f59a1f423425e
https://doi.org/10.1016/j.anai.2023.12.023

المؤلفون: Correa-Borit, Jorge, Laorden, Daniel, Arnalich Montiel, Victoria, Quirce, Santiago, Domínguez-Ortega, Javier

المصدر: J Asthma ; ISSN:1532-4303

مصطلحات موضوعية: Mepolizumab, biologic, interleukin 5, long-term, real world, remission, severe asthma, treatment response

Relation: https://doi.org/10.1080/02770903.2024.2441887; https://pubmed.ncbi.nlm.nih.gov/39661869

الاتاحة: https://doi.org/10.1080/02770903.2024.2441887
https://pubmed.ncbi.nlm.nih.gov/39661869

المؤلفون: Knutsson, Anki, Björkbacka, Harry, Dunér, Pontus, Engström, Gunnar, Binder, Christoph J., Nilsson, Anna Hultgårdh, Nilsson, Jan

المصدر: JACC: Basic to Translational Science EXODIAB: Excellence of Diabetes Research in Sweden EpiHealth: Epidemiology for Health. 4(8):891-902

مصطلحات موضوعية: atherosclerosis, interleukin 5, myocardial infarction, stroke, Medicin och hälsovetenskap, Klinisk medicin, Kardiologi, Medical and Health Sciences, Clinical Medicine, Cardiac and Cardiovascular Systems

URL الوصول: https://lup.lub.lu.se/record/9e38b917-ec10-48bb-8e5d-df924453ff41
http://dx.doi.org/10.1016/j.jacbts.2019.07.002

المؤلفون: Mitchell M. Pitlick, MD, James T. Li, MD, PhD, Thanai Pongdee, MD

المصدر: World Allergy Organization Journal, Vol 15, Iss 8, Pp 100676- (2022)

مصطلحات موضوعية: Eosinophil, Biologics, Interleukin 5, Treatment, Siglec-8, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1939455122000527; https://doaj.org/toc/1939-4551

URL الوصول: https://doaj.org/article/068b21f1aa104bcc92bb4558f2c99e9f

المؤلفون: Sylwia Biały, Milena Iwaszko, Jerzy Świerkot, Bartosz Bugaj, Katarzyna Kolossa, Sławomir Jeka, Katarzyna Bogunia-Kubik

المصدر: International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 13177

مصطلحات موضوعية: interleukin 5, interleukin 9, IL5, IL9, ankylosing spondylitis, anti-TNF, SNP

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Molecular Immunology; https://dx.doi.org/10.3390/ijms232113177

الاتاحة: https://doi.org/10.3390/ijms232113177

المؤلفون: Mattei, Laura, Suehs, Carey, Alagha, Khuder, Bourdin, Arnaud, Brousse, Christophe, Charriot, Jérémy, Devouassoux, Gilles, Fry, Stephanie, Guilleminault, Laurent, Gouitaa, Marion, Taille, Camille, Chanez, Pascal, Pahus, Laurie

المساهمون: Hôpital Nord CHU - APHM, Université de Montpellier (UM), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), CRP Clinique du Parc, Castelnau-Le-Lez, Physiologie & médecine expérimentale du Cœur et des Muscles U 1046 (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Plateforme F-CRIN, Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital de la Croix-Rousse CHU - HCL, Hospices Civils de Lyon (HCL), Inflammation et immunité de l'épithélium respiratoire, Université de Reims Champagne-Ardenne (URCA)-IFR53, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Institut Pasteur de Lille, Pasteur Network (Réseau International des Instituts Pasteur), Université de Lille, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Assistance Publique - Hôpitaux de Marseille (APHM), Aix Marseille Université (AMU), AP-HP - Hôpital Bichat - Claude Bernard Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Physiopathologie et Epidémiologie des Maladies Respiratoires (PHERE (UMR_S_1152 / U1152)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Etablissement Français du Sang Provence-Alpes Côte-d'Azur et Corse (EFS)

المصدر: ISSN: 1753-4658.

مصطلحات موضوعية: anti-interleukin 5, anti-interleukin 5 receptor, failure, severe asthma, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/34629000; PUBMED: 34629000; WOS: 000706194500001

الاتاحة: https://hal.science/hal-03374389
https://hal.science/hal-03374389v1/document
https://hal.science/hal-03374389v1/file/2021%20Mattei%20et%20al.,%20Anti%20interleukin%205.pdf
https://doi.org/10.1177/17534666211049735

المؤلفون: Idler, Beau M, Iijima, Koji, Ochkur, Sergei I, Jacobsen, Elizabeth A, Rank, Matthew A, Kita, Hirohito, Lal, Devyani

المصدر: Laryngoscope ; ISSN:1531-4995 ; Volume:134 ; Issue:1

مصطلحات موضوعية: IL-5, biomarker, chronic rhinosinusitis, eosinophil peroxidase, eosinophilia, interleukin 5, nasal polyps, sinusitis

Relation: https://doi.org/10.1002/lary.30787; https://pubmed.ncbi.nlm.nih.gov/37255054; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687314/

الاتاحة: https://doi.org/10.1002/lary.30787
https://pubmed.ncbi.nlm.nih.gov/37255054
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687314/

المؤلفون: Aydın, İ., Taşkın, R.B., Aytaç, G., Imamoglu, S., Tunçay, S.C., Bulut, İ.K., Karaca, N.E.

مصطلحات موضوعية: IgA vasculitis, polymerase chain reaction restriction fragment length polymorphism, real time polymerase chain reaction, Turk (people), young adult, anaphylactoid purpura, arthritis, gene expression, genetic polymorphism, genetic predisposition, genetics, single nucleotide polymorphism, ACE gene polymorphism, Proinflammatory cytokine gene polymorphisms, dipeptidyl carboxypeptidase, interleukin 1beta, interleukin 5, non receptor protein tyrosine phosphatase 22, transforming growth factor beta, messenger RNA, PTPN22 protein, human, adolescent, adult, allele specific polymerase chain reaction, Article, case control study, child, childhood, controlled study

Relation: Molecular Biology Reports; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11454/93200; https://doi.org/10.1007/s11033-023-08944-x; 51

الاتاحة: https://hdl.handle.net/11454/93200
https://doi.org/10.1007/s11033-023-08944-x

المؤلفون: Renz, Harald, Bachert, Claus, Berek, Claudia, Hamelmann, Eckard, Levi-Schaffer, Francesca, Raap, Ulrike, Simon, Hans-Uwe, Ploetz, Sabine, Taube, Christian, Valent, Peter, Voehringer, David, Werfel, Thomas, Zhang, Nan, Ring, Johannes

المصدر: SCANDINAVIAN JOURNAL OF IMMUNOLOGY ; ISSN: 0300-9475 ; ISSN: 1365-3083

مصطلحات موضوعية: Medicine and Health Sciences, anti‐, interleukin 5, DNAzyme against GATA3, eosinophil, diseases, hypereosinophilic syndrome

وصف الملف: application/pdf

Relation: https://biblio.ugent.be/publication/8706288; http://hdl.handle.net/1854/LU-8706288; http://dx.doi.org/10.1111/sji.13032; https://biblio.ugent.be/publication/8706288/file/8706289

الاتاحة: https://biblio.ugent.be/publication/8706288
http://hdl.handle.net/1854/LU-8706288
https://doi.org/10.1111/sji.13032
https://biblio.ugent.be/publication/8706288/file/8706289

المؤلفون: Joanna Sarbinowska, Benita Wiatrak, Dorota Waśko-Czopnik

المصدر: Biomolecules; Volume 11; Issue 6; Pages: 890

مصطلحات موضوعية: eosinophilic esophagitis, eotaxin 3, interleukin 5, interleukin 13, major basic protein, transforming growth factor beta 1

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Chemical Biology; https://dx.doi.org/10.3390/biom11060890

الاتاحة: https://doi.org/10.3390/biom11060890

المؤلفون: Akram Miramin-Mohammadi, Amir Javadi, Seyed Ebrahim Eskandari, Hossein Mortazavi, Mahmoud Nateghi Rostami, Ali Khamesipour

المصدر: Iranian Journal of Microbiology, Vol 12, Iss 3 (2020)

مصطلحات موضوعية: Cutaneous leishmaniasis, Soluble Leishmania antigen (SLA), Immune response, Interferon gamma (IFNγ), Interleukin 10 (IL-10), Interleukin 5 (IL-5), Microbiology, QR1-502

وصف الملف: electronic resource

Relation: https://ijm.tums.ac.ir/index.php/ijm/article/view/2488; https://doaj.org/toc/2008-3289; https://doaj.org/toc/2008-4447

URL الوصول: https://doaj.org/article/335cf5cb651b4ab69df39ed64d237784

المؤلفون: Raghdah Maytham Hameed, Mohanad Mohsin Ahmed, Haidar Abdul Amir Najim Abood

المصدر: Biomedical and Biotechnology Research Journal, Vol 3, Iss 3, Pp 156-161 (2019)

مصطلحات موضوعية: Bronchial asthma, eosinophil, interleukin 5, total IgE, Biotechnology, TP248.13-248.65

وصف الملف: electronic resource

Relation: http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2019;volume=3;issue=3;spage=156;epage=161;aulast=Hameed; https://doaj.org/toc/2588-9834; https://doaj.org/toc/2588-9842

URL الوصول: https://doaj.org/article/f6c247bf4c474be5896a74601f72c02b

المؤلفون: Raghdah Maytham Hameed, Haidar Abdul Amir Najim Abood, Mohanad Mohsin Ahmed, Aqeel Mahdi Hussein

المصدر: Biomedical and Biotechnology Research Journal, Vol 3, Iss 4, Pp 249-252 (2019)

مصطلحات موضوعية: asthma, eosinophil, interleukin 5, total serum immunoglobulin e, Biotechnology, TP248.13-248.65

وصف الملف: electronic resource

Relation: http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2019;volume=3;issue=4;spage=249;epage=252;aulast=Hameed; https://doaj.org/toc/2588-9834; https://doaj.org/toc/2588-9842

URL الوصول: https://doaj.org/article/7a4c228ab40c4c45b5a398ceab6e80da

المؤلفون: R. S. Fassakhov

المصدر: Медицинский совет, Vol 0, Iss 15, Pp 70-75 (2018)

مصطلحات موضوعية: severe bronchial asthma, eosinophilic inflammation, interleukin 5, reslisumab, Medicine

وصف الملف: electronic resource

Relation: https://www.med-sovet.pro/jour/article/view/2673; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790

URL الوصول: https://doaj.org/article/f6970dfcbfba46acabe05d686bcada21

المؤلفون: Andrea Matucci, Alessandra Vultaggio, Enrico Maggi, Ismail Kasujee

المصدر: Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)

مصطلحات موضوعية: Immunoglobulin E, IgE, Eosinophil, Interleukin 5, IL-5, Asthma pathogenesis, anti-IgE, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12931-018-0813-0; https://doaj.org/toc/1465-993X

URL الوصول: https://doaj.org/article/1446067af00b4c32bf00c0ba28afb187

المؤلفون: Hale ATEŞ, Kurtuluş AKSU, İlkay KOCA KALKAN, Musa TOPEL, Senay DEMİR, Selma YESİLKAYA, Sakine NAZİK BAHCECİOGLU

المصدر: Volume: 3, Issue: 3 275-279
Journal of Medicine and Palliative Care

مصطلحات موضوعية: Health Care Sciences and Services, Astım kontrol testi, interlökin–5, kan eozinofil sayıları, kortikosteroid, Asthma control test, blood eosinophil counts, corticosteroid, interleukin – 5, Sağlık Bilimleri ve Hizmetleri

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d7e829f237a1d9b5d2dac22e2dc57e3
https://doi.org/10.47582/jompac.1167677

المؤلفون: Boyce, Joshua A., Friend, Daniel, Gurish, Michael F., Austen, K. Frank, Owen, William F.

المصدر: Proceedings of the National Academy of Sciences of the United States of America, 1996 Mar . 93(6), 2436-2441.

URL الوصول: https://www.jstor.org/stable/38692

المؤلفون: Molano-González, Nicolas, Pacheco Nieva, Yovana, Rodríguez-Jímenez, Mónica, Rojas, Manuel, Monsalve, Diana M., Acosta-Ampudia, Yeny, Rodríguez, Yhojan, Ramirez-Santana, Carolina, Anaya, Juan-Manuel

المصدر: instname:Universidad del Rosario

مصطلحات موضوعية: Alpha interferon, Autoantibody, Gamma interferon, Granulocyte colony stimulating factor, Immunoglobulin g, Immunoglobulin m, Interleukin 10, Interleukin 12, Interleukin 13, Interleukin 17, Interleukin 1beta, Interleukin 2, Interleukin 4, Interleukin 5, Interleukin 6, Interleukin 8, Interleukin 9, Tumor necrosis factor, Adult, Antiphospholipid syndrome, Article, Autoimmune disease, Autoimmune hepatitis, Cluster analysis, Controlled study, Disease duration, Female, Human, Major clinical study, Myasthenia gravis

وصف الملف: application/pdf

Relation: https://repository.urosario.edu.co/handle/10336/22263; https://doi.org/10.1016/j.jaut.2018.11.002

الاتاحة: https://repository.urosario.edu.co/handle/10336/22263
https://doi.org/10.1016/j.jaut.2018.11.002

المؤلفون: Natal'ya M. Nenasheva, Н. М. Ненашева

المصدر: PULMONOLOGIYA; Том 29, № 2 (2019); 216-228 ; Пульмонология; Том 29, № 2 (2019); 216-228 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2019-29-2

مصطلحات موضوعية: биологическая терапия бронхиальной астмы, severe asthma, phenotype, endotype, interleukin 4, interleukin 5, interleukin 13, biomarkers of T2 inflammation, biological therapy for asthma, тяжелая бронхиальная астма, фенотип, эндотип, интерлейкины-4, биомаркеры Т2-воспаления

وصف الملف: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/1148/912; Soriano J.B., Abajobir A.A., Abate K.H. et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir. Med. 2017; 5 (9): 691–706. DOI:10.1016/S2213-2600(17)30293-X.; Bousqet J., Mantzouranis E., Cruz A.A. et al. Uniform definition of asthma severity, control and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J. Allergy Clin. Immunol. 2010; 126 (5): 926–938. DOI:10.1016/j.jaci.2010.07.019.; Chung K.F., Wenzel S.E., Brozek J.L. et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J. 2014; 43 (2): 343–373. DOI:10.1183/09031936.00202013.; GINA 2018. Difficult-to-Treat & Severe Asthma in adolescent and adult patients: Diagnosis and management. A GINA Pocket Guide for Health Professionals. Available at: https://ginasthma.org/wp-content/uploads/2018/11/GINA-SA-FINAL-wms.pdf [Accessed: March 6, 2019].; Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология. 2011; (6): 87–93.; Харитонс М.А., Рамазанова К.А. Современные представления о лечении бронхиальной астмы. Терра Медика Нова. 2001; (1). Доступно на: https://medi.ru/info/6513/ [Дата обращения: 06.03.19].; Астафьева Н.Г., Гамова И.В., Удовиченко Е.Н. и др. Клинические фенотипы бронхиальной астмы у подростков: трудности диагностики и терапии. Лечащий врач. 2015; (4): 20–23.; Куличенко Т.В. Омализумаб у детей с бронхиальной астмой: показания к применению. Педиатрическая фармакология. 2007; 4 (6): 51–55.; Busse W.W., Banks-Schlegel S., Wenzel S.E. Pathophysiology of severe asthma. J. Allergy Clin. Immunol. 2000; 106 (6): 1033–1042. DOI:10.1067/mai.2000.111307.; O'Byrne P.M., Naji N., Gauvreau G.M. Severe asthma: future treatments. Clin. Exp. Allergy. 2012; 42 (5): 706–711. DOI:10.1111/j.1365-2222.2012.03965.x.; Hekking P.P., Wener R.R., Amelink M. et al. The prevalence of severe refractory asthma. J. Allergy Clin. Immunol. 2015; 135 (4): 896–902. DOI:10.1016/j.jaci.2014.08.042.; Miller M.K., Lee J.H., Miller D.P., Wenzel S.E. Recent asthma exacerbations: a key predictor of future exacerbations. Respir. Med. 2007; 101 (3): 481–489. DOI:10.1016/j.rmed.2006.07.005.; Bai T.R., Vonk J.M., Postma D.S., Boezen H.M. Severe exacerbations predict excess lung function decline in asthma. Eur. Respir. J. 2007; 30 (3): 452–456. DOI:10.1183/09031936.00165106; Федеральные клинические рекомендации по диагностике и лечению бронхиальной астмы. М.: Российское респираторное общество, Российская ассоциация аллергологов и клинических иммунологов; 2018. Доступно на: http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ [Дата обращения: 16.03.19].; Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2018. Available at: https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-V1.3-002.pdf [Дата обращения: 16.03.19].; Ненашева Н.М. Бронхиальная астма. Современный взгляд на проблему. М.: ГЭОТАР-Медиа; 2018.; Anderson G.P. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008; 372 (9643): 1107–1019. DOI:10.1016/S0140-6736(08)61452-X.; Woodruff P.G., Modrek B., Choy D.F. et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 2009; 180 (5): 388–395. DOI:10.1164/rccm.200903-0392OC.; Bhakta N.R., Woodruff P.G. Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol. Rev. 2011; 242 (1): 220–232. DOI:10.1111/j.1600-065X.2011.01032.x.; Brusselle G.G., Maes T., Bracke K.R. Eosinophils in the spotlight: Eosinophilic airway inflammation in nonallergic asthma. Nat. Med. 2013; 19 (8): 977–979. DOI:10.1038/nm.3300.; Wenzel S. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 2012; 18 (5): 716–725. DOI:10.1038/nm.2678.; Сергеева Г.Р., Емельянов А.В., Коровина О.В. и др. Тяжелая бронхиальная астма: характеристика пациентов в клинической практике. Терапевтический архив. 2015; 87 (12): 26–31. DOI:10.17116/terarkh2015871226-31.; Denlinger L.C., Phillips B.R., Ramrathan S. et al. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations. Am. J. Respir. Crit. Care Med. 2017; 195 (3): 302–313. DOI:10.1164/rccm.201602-0419OC.; Kupczyk M., ten Brinke A., Sterk P.J. et al. Frequent exacerbators – a distinct phenotype of severe asthma. Clin. Exp. Allergy. 2013; 44 (2): 212–221. DOI:10.1111/cea.12179.; Price D., Wilson A.M., Chisholm A. et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J. Asthma Allergy. 2016; 9: 1–12. DOI:10.2147/JAA.S97973.; Castro M., Zangrilli J., Wechlser M.E. et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicenter, parallel, double-blind, randomized, placebo-controlled, phase 3 trials. Lancet Respir. Med. 2015; 3 (5): 355–366. DOI:10.1016/S2213-2600(15)00042-9.; Pavord I.D., Korn S., Howarth P. et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012; 380 (9842): 651–659. DOI:10.1016/S0140-6736(12)60988-X.; Bleecker E.R., FitzGerald J.M., Chanez P. et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet. 2016; 388 (10056): 2115–2127. DOI:10.1016/S0140-6736(16)31324-1.; Hanania N.A., Alpan O., Hamilos D.L. et al. Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. Ann. Intern. Med. 2011; 154 (9): 573–582. DOI:10.7326/0003-4819-154-9-201105030-00002.; Katial R.K., Bensch G.W., Busse W.W. et al. Changing paradigms in the treatment of severe asthma: The role of biologic therapies. J. Allergy Clin. Immunol. Pract. 2017; 5 (2, Suppl.): S1–S14. DOI:10.1016/j.jaip.2016.11.029.; Fajt M.L., Wenzel S.E. Development of new therapies for severe asthma. Allergy Asthma Immunol. Res. 2017; 9 (1): 3–14. DOI:10.4168/aair.2017.9.1.3.; Israel E., Reddel H.K. Severe and difficult-to-treat asthma in adults. N. Engl. J. Med. 2017; 377 (10): 965–976. DOI:10.1056/NEJMra1608969.; Li B.W., Hendriks R.W. Group 2 innate lymphoid cells in lung inflammation. Immunology. 2013; 140 (3): 281–287. DOI:10.1111/imm.12153.; Kim H.Y., Umetsu D.Т., Dekruyff R.Н. Innate lymphoid cells in asthma: Will they take your breath away? Eur. J. Immunol. 2016; 46 (4): 795–806. DOI:10.1002/eji.201444557.; Kau A.L., Korenblat P.E. Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes. Curr. Opin. Allergy Clin. Immunol. 2014; 14 (6): 570–575. DOI:10.1097/ACI.0000000000000108.; Gandhi N.A., Bennett B.L., Graham N.M. et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat. Rev. Drug Discov. 2016; 15 (1): 35–50. DOI:10.1038/nrd4624.; Coffman R.L. Converging discoveries: The first reports of IL-4. J. Immunol. 2013; 190 (3): 847–848. DOI:10.4049/jimmunol.1203368.; Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 2004; 202: 175–190. DOI:10.1111/j.0105-2896.2004.00215.x; Brusselle G., Kips J., Joos G. et al. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 1995; 12 (3): 254–259. DOI:10.1165/ajrcmb.12.3.7873190.; Gavett S.H., O’Hearn D.J., Karp C.L. et al. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am. J. Physiol. 1997; 272 (2, Pt 1): L253–L261. DOI:10.1152/ajplung.1997.272.2.L253.; Corry D.B., Folkesson H.G., Warnock M.L. et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 1996; 183 (1): 109–117. DOI:10.1084/jem.183.1.109.; Henderson W.R. Jr, Chi E.Y., Maliszewski C.R. Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J. Immunol. 2000; 164 (2): 1086–1095. DOI:10.4049/jimmunol.164.2.1086.; Dabbagh K., Takeyama K., Lee H.M. et al. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol. 1999; 162 (10): 6233–6237.; Tepper R.I., Levinson D.А., Stanger B.Z. et al. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell. 1990; 62 (3): 457–467.; Wills-Karp M., Luyimbazi J., Xu X. et al. Interleukin-13: central mediator of allergic asthma. Science. 1998; 282 (5397): 2258–2261.; Grünig G., Warnock M., Wakil A. et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998; 282 (5397): 2261–2263.; Zhu Z., Homer R.J., Wang Z. et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 1999; 103 (6): 779–788. DOI:10.1172/JCI5909.; Webb D.C., McKenzie A.N., Koskinen A.M. et al. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J. Immunol. 2000; 165 (1): 108–113. DOI:10.4049/jimmunol.165.1.108.; Kuperman D.A., Huang X., Koth L.L. et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 2002; 8 (8): 885–889. DOI:10.1038/nm734.; Gour N., Wills-Karp M. IL-4 and IL-13 signaling in allergic airway disease. Cytokine. 2015; 75 (1): 68–78. DOI:10.1016/j.cyto.2015.05.014.; Rosenberg H.F., Dyer K.D., Foster P.S. Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol. 2013; 13 (1): 9–22. DOI:10.1038/nri3341.; Louis R., Sele J., Henket M. et al. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy. 2002; 57 (10): 907–912.; Chung K.F. Personalised medicine in asthma: time for action. Eur. Respir. Rev. 2017; 26 (145): pii: 170064. DOI:10.1183/16000617.0064-2017.; Ненашева Н.М. Значение биомаркеров в диагностике и терапии бронхиальной астмы. Практическая пульмонология. 2017; (4): 3–9.; de Groot J.C., Storm H., Amelink M. et al. Clinical profile of patients with adult-onset eosinophilic asthma. ERJ Open Res. 2016; 2 (2): pii: 00100-2015. DOI:10.1183/23120541.00100-2015.; de Groot J.C., Ten Brinke A., Bel E.H. Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res. 2015; 1 (1): pii: 00024-2015. DOI:10.1183/23120541.00024-2015.; Haldar P., Brightling C.E., Hargadon B. et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med. 2009; 360 (10): 973–984. DOI:10.1056/NEJMoa0808991.; Castro M., Mathur S., Hargreave F. et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am. J. Respir. Crit. Care Med. 2011; 184 (10): 1125–1132. DOI:10.1164/rccm.201103-0396OC.; Wenzel S., Ford L., Pearlman D. et al. Dupilumab in persistent asthma with elevated eosinophil levels. N. Engl. J. Med. 2013; 368 (26): 2455–2466. DOI:10.1056/NEJMoa1304048.; Castro M., Wenzel S.E., Bleecker E.R. et al. Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study. Lancet Respir. Med. 2014; 2 (11): 879–890. DOI:10.1016/S2213-2600(14)70201-2.; Castro M., Corren J., Pavord I.D. et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N. Engl. J. Med. 2018; 378 (26): 2486–2496. DOI:10.1056/NEJMoa1804092.; Fitzpatrick A.M. Biomarkers of asthma and allergic airway diseases. Ann. Allergy Asthma Immunol. 2015; 115 (5): 335–340. DOI:10.1016/j.anai.2015.09.003.; Dweik R.A., Boggs P.B., Erzurum S.C. et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med. 2011; 184 (5): 602–615. DOI:10.1164/rccm.9120-11ST.; Smith A.D., Cowan J.O., Brasset K.P. et al. Exhaled nitric oxide: A predictor of steroid response. Am. J. Respir. Crit. Care Med. 2005; 172 (4): 453–459. DOI:10.1164/rccm.200411-1498OC.; Hanania N.A., Wenzel S., Rosén K. et al. Exploring the effect of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am. J. Respir. Crit. Care Med. 2013; 187 (8): 804–811. DOI:10.1164/rccm.201208-1414OC.; https://journal.pulmonology.ru/pulm/article/view/1148

الاتاحة: https://journal.pulmonology.ru/pulm/article/view/1148
https://doi.org/10.18093/0869-0189-2019-29-2-216-228

المؤلفون: Wirawan, Tommy Nugroho, Barlianto, Wisnu, Kusuma, HMS Chandra

المصدر: Majalah Kesehatan FKUB; Vol. 6 No. 2 (2019): Majalah Kesehatan; pp.86-95 ; 2548-7698 ; 1907-8803

مصطلحات موضوعية: asma, interleukin 5, CD4, CD8

وصف الملف: application/pdf

Relation: https://majalahfk.ub.ac.id/index.php/mkfkub/article/view/305/170; https://majalahfk.ub.ac.id/index.php/mkfkub/article/view/305

الاتاحة: https://majalahfk.ub.ac.id/index.php/mkfkub/article/view/305
https://doi.org/10.21776/ub.majalahkesehatan.006.02.2